Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 14
Encontrada(s) 1 página(s)

Docta Complutense
Publication Artículo científico (JournalArticle)

Paliperidone attenuates chronic stress-induced changes in the expression of inflammasomes-related protein in the frontal cortex of male rats

  • Mac-Dowell Mata, Karina Soledad
  • Martín Hernández, David
  • Ulecia Morón, Cristina
  • González Bris, Álvaro
  • Muñoz Madrigal, José Luis
  • García Bueno, Borja
  • Caso Fernández, Javier Rubén
Several stress-related neuropsychiatric diseases are related to inflammatory phenomena. Thus, a better understanding of stress-induced immune responses could lead to enhanced treatment alternatives. Little is known about the possible involvement of inflammasomes in the stress-induced proinflammatory response. Antipsychotics have anti-inflammatory effects, but the possible antipsychotic treatment actions on inflammasomes remain unexplored. Our aim was to study whether inflammasomes are involved in the neuroinflammation induced by a paradigmatic model of chronic stress and whether the monoamine receptor antagonist paliperidone can modulate the possible stress-induced inflammasomes activation in the frontal cortex (FC). Thus, the effects of paliperidone (1 mg/Kg, oral gavage) administered during a chronic restraint stress protocol (6 h/day for 21 days) on the possible stress-related inflammasomes protein induction were evaluated through Western blot in the FC of male Wistar rats. Stress increased protein expression levels of the inflammasome complexes NALP1, NLRP3 and AIM2 and augmented caspase-1 and mature interleukin (IL)-1β protein levels. Paliperidone pre-treatment normalized the protein expression of the inflammasome pathway. In conclusion, our data indicate an induction of inflammasome complexes by chronic restraint stress in the FC of rats. The antipsychotic paliperidone has an inhibitory action on some of the stress-induced inflammasomes stimulation trying to normalize the neuroinflammatory scenario caused by stress. Considering the emerging role of inflammation in neuropsychiatric diseases, the development of new drugs targeting inflammasome pathways is a promising approach for future therapeutic interventions.
DAU Arxiu Digital de la Universitat Ramon Llull
Publication Artículo científico (JournalArticle)

Nitrogen positional scanning in tetramines active against HIV-1 as potential CXCR4 inhibitors

  • Borrell, Jose I.
  • Puig de la Bellacasa, Raimon
  • Gibert-Bosch, Albert
  • Planesas, Jesús M.
  • Ros-Blanco, Laia
  • Batllori Aguilà, Xavier
  • Badía, Roger
  • Clotet i Sala, Bonaventura
  • Esté, José A.
  • Teixidó, Jordi
The paradigm, derived from bicyclams and other cyclams, by which it is necessary to use the p-phenylene moiety as the central core in order to achieve high HIV-1 antiviral activities has been reexamined for the more flexible and less bulky structures 4, previously described by our group as potent HIV-1 inhibitors. The symmetrical compounds 7{x,x} and the non-symmetrical compounds 8{x,y} were designed, synthesized and biologically evaluated in order to explore the impact on the biological activity of the distance between the phenyl ring and the first nitrogen atom of the side chains. EC50 exactly followed the order 7{x,x} < 8{x,x} < 4{x,x} indicating that, for such flexible tetramines, the presence of two methylene units on each side of the central phenyl ring increases the biological activity contrary to AMD3100. A computational study of the interactions of 4{3,3}, 7{3,3} and 8{3,3} with CXCR4 revealed interactions in the same pocket region with similar binding modes for 4{3,3} and 7{3,3} but a different one for 8{3,3}.
Helvia. Repositorio Institucional de la Universidad de Córdoba
Publication Artículo científico (JournalArticle)

Long-term dietary adherence and changes in dietary intake in coronary patients after intervention with a Mediterranean diet or a low-fat diet: the CORDIOPREV randomized trial

  • Quintana-Navarro, Gracia M.
  • Alcalá Díaz, Juan Francisco
  • López-Moreno, Javier
  • Pérez‑Corral, Isabel
  • León-Acuña, Ana
  • Torres‑Peña, J.D.
  • Rangel Zúñiga, Oriol Alberto
  • Arenas de Larriva, Antonio P.
  • Corina Baba, Andreea
  • Camargo García, A.
  • Yubero-Serrano, Elena M.
  • Rodríguez-Cantalejo, Fernando
  • García-Ríos, Antonio
  • Luque, R.M.
  • Ordovás, José María
  • Pérez-Martínez, Pablo
  • López-Miranda, José
  • Delgado-Lista, Javier
Purpose: Adherence to a healthy dietary pattern positively influences clinical outcomes in cardiovascular prevention, but long-term adherence is difficult to maintain. We evaluated 5-year changes in dietary habits, adherence achieved, and its maintenance in a cohort of coronary patients from the CORDIOPREV study. Methods: 1002 coronary patients were randomized to a Mediterranean diet (n = 502) or a low-fat diet (n = 500) and received individual-group-telephone visits and personalized dietary advice. A validated food-frequency questionnaire, a 14-point Mediterranean diet adherence screener, and a 9-point low-fat diet adherence score were used. Dietary adherence was categorized into Low, Medium, and High Adherence. Changes in nutrient intake, food consumption, and adherence were analyzed on a yearly basis. The maintenance of long-term dietary adherence was evaluated using data after the first year and fifth year. Results: From baseline to 5 years, significant increases were observed in overall dietary adherence (Mediterranean diet from 8.9 to 11.4; low-fat diet from 3.9 to 7.1) and in the percentage of patients considered High Adherence (Mediterranean diet from 41 to 89%; low-fat diet from 4 to 67%). When we evaluated the maintenance of adherence, patients considered Low and Medium Adherence at 1 year increased their adherence at the 5 years with both diets and patients considered High Adherence maintained their adherence with a Mediterranean diet, but decreased their adherence with a low-fat diet. Conclusions: A comprehensive dietary intervention results in an overall long-term improvement and maintenance of adherence to the Mediterranean and low-fat diets. In our population, the Mediterranean diet group achieved a high level of adherence in the short term which was maintained in the long term.
Helvia. Repositorio Institucional de la Universidad de Córdoba
Publication Artículo científico (JournalArticle)

Risk of short telomere as biomarker of diabetes mellitus type 2 status in the CORDIOPREV study, Riesgo de telómero corto como biomarcador de diabetes mellitus tipo 2 en el estudio CORDIOPREV

  • Ojeda-Rodríguez, Ana
  • Párraga-Viudez, María José
  • Romero-Cabrera, Juan Luis
  • López-Moreno, Alejandro
  • Arenas-Montes, Javier
  • Pérez-Caballero, Ana I.
  • Luque, Raúl M.
  • Delgado-Lista, Javier
  • Rangel-Zuñiga, Oriol Alberto
  • López-Miranda, José
Embargado hasta 19/12/2026, Background The presence of type 2 diabetes mellitus (T2DM) in cardiovascular disease (CVD) is associated with poorer clinical outcomes. To identify biomarkers is essential to predict T2DM onset and progression in the context of secondary prevention. Telomere length (TL), a marker of cellular aging, has been linked to oxidative stress, inflammation, and metabolic dysfunction, including diabetes-related complications. This study aims to evaluate TL as a potential biomarker for T2DM in patients with coronary heart disease (CHD). Methods We included 956 patients from the CORDIOPREV study with available TL data. Participants were classified according to their diabetes status at the end of the dietary intervention: 407 were free of T2DM and 549 were classified as having T2DM. TL was measured by quantitative PCR. Patients with TL values below the 20th percentile of the study population were categorized as having short telomeres. Results TL was significantly shorter in T2DM patients compared to non-T2DM (1.26 ± 0.74 vs. 1.38 ± 0.84; p = 0.026). Each 1-SD increase in TL was associated with a 17% lower risk of T2DM (OR 0.83, 95% CI 0.69–0.98). Patients at risk of short TL (<20th percentile) showed a higher prevalence of T2DM (20% vs. 17%; p = 0.035) and a 42% increased risk of its presence (OR 1.42, 95% CI 0.99–2.02). In stepwise regression models, TL, age, BMI, insulin, triglycerides, and HbA1c emerged as independent predictors of T2DM. After adjusting for fasting glucose, TL lost significance as a continuous variable, but short TL risk remained independently associated with T2DM (OR 1.57, p = 0.049). Conclusions Shorter TL is associated with the presence of T2DM in patients with CHD, supporting its potential role as an independent biomarker for T2DM risk in secondary prevention., Resumen Antecedentes La presencia de diabetes mellitus tipo 2 (DMT2) en la enfermedad cardiovascular se asocia con peores resultados clínicos. Identificar biomarcadores es esencial para predecir la aparición y progresión de la DMT2 en el contexto de la prevención secundaria. La longitud de los telómeros (LT), un marcador de envejecimiento celular se ha relacionado con el estrés oxidativo, la inflamación y la disfunción metabólica, incluidas las complicaciones asociadas a la diabetes. Este estudio tiene como objetivo evaluar la LT como un biomarcador potencial de la DMT2 en pacientes con enfermedad coronaria (EC). Métodos Se incluyeron 956 pacientes del estudio CORDIOPREV con datos disponibles de LT. Los participantes fueron clasificados según su estado diabético al final de la intervención dietética: 407 estaban libres de DMT2 y 549 fueron clasificados con DMT2. La LT se midió mediante PCR cuantitativa. Los pacientes con valores de LT por debajo del percentil 20 de la población del estudio fueron categorizados como en riesgo de telómeros cortos. Resultados La LT fue significativamente más corta en los pacientes con DMT2 en comparación con los no diabéticos (1,26 ± 0,74 vs. 1,38 ± 0,84; p = 0,026). Cada incremento de 1 DE en LT se asoció con un 17% menos de riesgo de DMT2 (OR 0,83; IC 95%: 0,69–0,98). Los pacientes en riesgo de LT corta (< percentil 20) mostraron una mayor prevalencia de DMT2 (20% vs. 17%; p = 0,035) y un aumento del 42% en el riesgo de su presencia (OR 1,42; IC 95%: 0,99–2,02). En los modelos de regresión por pasos, la LT, la edad, el IMC, la insulina, los triglicéridos y la HbA1c emergieron como predictores independientes de la DMT2. Tras ajustar por glucosa en ayunas, la LT perdió significancia como variable continua, pero el riesgo de LT corta permaneció asociado de manera independiente con la DMT2 (OR 1,57; p = 0,049). Conclusiones Una LT más corta se asocia con la presencia de DMT2 en pacientes con EC, lo que respalda su potencial papel como biomarcador independiente de riesgo de DMT2 en prevención secundaria.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

The relationship of the atlantic diet with cardiovascular risk factors and markers of arterial stiffness in adults without cardiovascular disease

  • Rodríguez-Martín, C.
  • Garcia-Ortiz, L.
  • Rodriguez-Sanchez, E.
  • Martin-Cantera, C.
  • Soriano-Cano, A.
  • Arietaleanizbeaskoa, M.S.
  • Magdalena-Belio, J.F.
  • Menendez-Suarez, M.
  • Maderuelo-Fernandez, J.A.
  • Lugones-Sanchez, C.
  • Gómez-Marcos, M.A.
  • Recio-Rodríguez, J.I.
  • EVIDENT, Investigators, Group
Background: Studying the adherence of the population to the Atlantic Diet (AD) could be simplified by an easy and quickly applied dietary index. The aim of this study is to analyse the relationship of an index measuring compliance with recommendations regarding the Atlantic diet and physical activity with cardiovascular disease risk factors, cardiovascular risk factors, obesity indexes and arterial stiffness markers. Methods: We included 791 individuals from the EVIDENT study (lifestyles and arterial ageing), (52.3 ± 12 years, 61.7% women) without cardiovascular disease. Compliance with recommendations on AD was collected through the responses to a food frequency questionnaire, while physical activity was measured by accelerometer. The number of recommendations being met was estimated using a global scale between 0 and 14 points (a higher score representing greater adherence). Blood pressure, plasma lipid and glucose values and obesity rates were measured. Cardiovascular risk was estimated with the Framingham equation. Results: In the overall sample, 184 individuals (23.3%) scored between 0–3 on the 14-point index we created, 308 (38.9%) between 4 and 5 points, and 299 (37.8%) 6 or more points. The results of multivariate analysis yield a common tendency in which the group with an adherence score of at least 6 points shows lower figures for total cholesterol (p = 0.007) and triglycerides (p = 0.002). Similarly, overall cardiovascular risk in this group is the lowest (p < 0.001), as is pulse wave velocity (p = 0.050) and the mean values of the obesity indexes studied (p < 0.05 in all cases). Conclusion: The rate of compliance with the Atlantic diet and physical activity shows that greater adherence to these recommendations is linked to lower cardiovascular risk, lower total cholesterol and triglycerides, lower rates of obesity and lower pulse wave velocity values.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Nitrogen positional scanning in tetramines active against HIV-1 as potential CXCR4 inhibitors

  • Borrell, Jose I.
  • Puig de la Bellacasa, Raimon
  • Gibert-Bosch, Albert
  • Planesas, Jesús M.
  • Ros-Blanco, Laia
  • Batllori Aguilà, Xavier
  • Badía, Roger
  • Clotet i Sala, Bonaventura
  • Esté, José A.
  • Teixidó, Jordi
The paradigm, derived from bicyclams and other cyclams, by which it is necessary to use the p-phenylene moiety as the central core in order to achieve high HIV-1 antiviral activities has been reexamined for the more flexible and less bulky structures 4, previously described by our group as potent HIV-1 inhibitors. The symmetrical compounds 7{x,x} and the non-symmetrical compounds 8{x,y} were designed, synthesized and biologically evaluated in order to explore the impact on the biological activity of the distance between the phenyl ring and the first nitrogen atom of the side chains. EC50 exactly followed the order 7{x,x} < 8{x,x} < 4{x,x} indicating that, for such flexible tetramines, the presence of two methylene units on each side of the central phenyl ring increases the biological activity contrary to AMD3100. A computational study of the interactions of 4{3,3}, 7{3,3} and 8{3,3} with CXCR4 revealed interactions in the same pocket region with similar binding modes for 4{3,3} and 7{3,3} but a different one for 8{3,3}.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Peroxynitrite formed during a transient episode of brain ischemia increases endothelium-derived hyperpolarization-type dilations in thromboxane/prostaglandin receptor-stimulated rat cerebral arteries

  • Onetti Vilalta, Yara
  • Dantas, A. P.|||0000-0001-8514-4094
  • Pérez, Belén|||0000-0001-5801-1704
  • McNeish, Alister J.
  • Vila Calsina, Elisabet|||0000-0001-8817-9399
  • Jiménez Altayó, Francesc|||0000-0002-9034-2041
AIM: Increased thromboxane A2 and peroxynitrite are hallmarks of cerebral ischaemia/reperfusion (I/R). Stimulation of thromboxane/prostaglandin receptors (TP) attenuates endothelium-derived hyperpolarization (EDH). We investigated whether EDH-type middle cerebral artery (MCA) relaxations following TP stimulation are altered after I/R and the influence of peroxynitrite. METHODS: Vascular function was determined by wire myography after TP stimulation with the thromboxane A2 mimetic 9,11-dideoxy-9α, 11α -methano-epoxy prostaglandin F2α (U46619) in MCA of Sprague Dawley rats subjected to MCA occlusion (90 min)/reperfusion (24 h) or sham operation, and in non-operated (control) rats. Some rats were treated with saline or the peroxynitrite decomposition catalyst 5,10,15,20-tetrakis(4-sulfonatophenyl)porphyrinato iron (III) (20 mg kg-1 ). Protein expression was evaluated in MCA and in human microvascular endothelial cells submitted to hypoxia (overnight)/reoxygenation (24 h) (H/R) using immunofluorescence and immunoblotting. RESULTS: In U46619-pre-constricted MCA, EDH-type relaxation by the proteinase-activated receptor 2 agonist serine-leucine-isoleucine-glycine-arginine-leucine-NH2 (SLIGRL) was greater in I/R than sham rats due to an increased contribution of small-conductance calcium-activated potassium channels (SKCa ), which was confirmed by the enlarged relaxation to the SKCa activator N-cyclohexyl-N-2-(3,5-dimethyl-pyrazol-1-yl)-6-methyl-4-pyrimidinamine. I/R and H/R induced endothelial protein tyrosine nitration and filamentous-actin disruption. In control MCA, either cytochalasin D or peroxynitrite disrupted endothelial filamentous-actin and augmented EDH-type relaxation. Furthermore, peroxynitrite decomposition during I/R prevented the increase in EDH-type responses. CONCLUSION: Following TP stimulation in MCA, EDH-type relaxation to SLIGRL is greater after I/R due to endothelial filamentous-actin disruption by peroxynitrite, which prevents TP-induced block of SKCa input to EDH. These results reveal a novel mechanism whereby peroxynitrite could promote post-ischaemic brain injury.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

MET expression and copy number heterogeneity in nonsquamous non-small cell lung cancer (nsNSCLC)

  • Casadevall Aguilar, David
  • Gimeno Beltran, Javier|||0000-0001-6085-5228
  • Clavé, Sergi|||0000-0002-9435-8454
  • Taus, Álvaro|||0000-0002-7331-6730
  • Pijuan, Lara|||0000-0002-9978-6933
  • Arumí, Miriam
  • Lorenzo, Marta
  • Menéndez, Silvia
  • Cañadas, Israel
  • Albanell Mestres, Joan|||0000-0003-1239-4580
  • Serrano, Sergio
  • Espinet i Solà, Blanca
  • Salido, Marta|||0000-0001-9988-5977
  • Arriola, Edurne|||0000-0001-8960-7519
We aimed to assess MET intratumoral heterogeneity and its potential impact on biomarker-based patient selection as well as potential surrogate biomarkers of MET activation. Our study included 120 patients with non-squamous Non-small-cell Lung Cancer (nsNSCLC), of which 47 were incorporated in tissue microarrays (TMA). Four morphologically distinct tumor areas were selected to assess MET heterogeneity. MET positivity by immunohistochemistry (IHC) was defined as an above-median H-score and by +2/+3 staining intensity in.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Recognition of Fibrotic Infarct Density by the Pattern of Local Systolic-Diastolic Myocardial Electrical Impedance

  • Amorós Figueras, Gerard|||0000-0002-2109-5550
  • Jorge, Esther|||0000-0002-2777-0000
  • García Sánchez, Tomás
  • Bragos, Ramon|||0000-0002-1373-1588
  • Rosell Ferrer, Javier|||0000-0002-9691-328X
  • Cinca, Juan|||0000-0003-4819-4265
Myocardial electrical impedance is a biophysical property of the heart that is influenced by the intrinsic structural characteristics of the tissue. Therefore, the structural derangements elicited in a chronic myocardial infarction should cause specific changes in the local systolic-diastolic myocardial impedance, but this is not known. This study aimed to characterize the local changes of systolic-diastolic myocardial impedance in a healed myocardial infarction model. Six pigs were successfully submitted to 150 min of left anterior descending (LAD) coronary artery occlusion followed by reperfusion. 4 weeks later, myocardial impedance spectroscopy (1-1000 kHz) was measured at different infarction sites. The electrocardiogram, left ventricular (LV) pressure, LV dP/dt, and aortic blood flow (ABF) were also recorded. A total of 59 LV tissue samples were obtained and histopathological studies were performed to quantify the percentage of fibrosis. Samples were categorized as normal myocardium (<10% fibrosis), heterogeneous scar (10-50%) and dense scar (.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Strategies to Inhibit Myc and Their Clinical Applicability

  • Whitfield, Jonathan R.|||0000-0002-4925-7283
  • Beaulieu, Marie-Eve|||0000-0001-5224-8436
  • Soucek, Laura|||0000-0002-4750-7971
Myc is an oncogene deregulated in most-perhaps all-human cancers. Each Myc family member, c-, L-, and N-Myc, has been connected to tumor progression and maintenance. Myc is recognized as a "most wanted" target for cancer therapy, but has for many years been considered undruggable, mainly due to its nuclear localization, lack of a defined ligand binding site, and physiological function essential to the maintenance of normal tissues. The challenge of identifying a pharmacophore capable of overcoming these hurdles is reflected in the current absence of a clinically-viable Myc inhibitor. The first attempts to inhibit Myc used antisense technology some three decades ago, followed by small molecule inhibitors discovered through "classical" compound library screens. Notable breakthroughs proving the feasibility of systemic Myc inhibition were made with the Myc dominant negative mutant Omomyc, showing both the great promise in targeting this infamous oncogene for cancer treatment as well as allaying fears about the deleterious side effects that Myc inhibition might have on normal proliferating tissues. During this time many other strategies have appeared in an attempt to drug the undruggable, including direct and indirect targeting, knockdown, protein/protein and DNA interaction inhibitors, and translation and expression regulation. The inhibitors range from traditional small molecules to natural chemicals, to RNA and antisense, to peptides and miniproteins. Here, we briefly describe the many approaches taken so far, with a particular focus on their potential clinical applicability.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

A baseline metabolomic signature is associated with immunological CD4 + T-cell recovery after 36 months of antiretroviral therapy in HIV-infected patients

  • Rodríguez-Gallego, Esther|||0000-0002-6363-2510
  • Pacheco, Yolanda M.|||0000-0002-9451-8083
  • Peraire, Joaquim|||0000-0001-7808-5479
  • Viladés, Consuelo|||0000-0002-2991-9593
  • Beltrán-Debón, Raúl|||0000-0001-9691-1906
  • Mallol, Roger
  • López Dupla, Miguel
  • Veloso Esteban, Sergio|||0000-0001-7943-1169
  • Alba, Verónica|||0000-0002-5925-9573
  • Blanco, Julià|||0000-0002-2225-0217
  • Cañellas, Nicolau
  • Rull, Anna|||0000-0002-8907-7754
  • Leal, Manuel
  • Correig, Xavier|||0000-0002-6902-3054
  • Domingo Pedrol, Pedro|||0000-0003-1138-5770
  • Vidal, Francesc|||0000-0002-6692-6186
Poor immunological recovery in treated HIV-infected patients is associated with greater morbidity and mortality. To date, predictive biomarkers of this incomplete immune reconstitution have not been established. We aimed to identify a baseline metabolomic signature associated with a poor immunological recovery after antiretroviral therapy (ART) to envisage the underlying mechanistic pathways that influence the treatment response. This was a multicentre, prospective cohort study in ART-naive and a pre-ART low nadir (<200 cells/μl) HIV-infected patients (n = 64). We obtained clinical data and metabolomic profiles for each individual, in which low molecular weight metabolites, lipids and lipoproteins (including particle concentrations and sizes) were measured by NMR spectroscopy. Immunological recovery was defined as reaching CD4 + T-cell count at least 250 cells/μl after 36 months of virologically successful ART. We used univariate comparisons, Random Forest test and receiver-operating characteristic curves to identify and evaluate the predictive factors of immunological recovery after treatment. HIV-infected patients with a baseline metabolic pattern characterized by high levels of large high density lipoprotein (HDL) particles, HDL cholesterol and larger sizes of low density lipoprotein particles had a better immunological recovery after treatment. Conversely, patients with high ratios of non-HDL lipoprotein particles did not experience this full recovery. Medium very-low-density lipoprotein particles and glucose increased the classification power of the multivariate model despite not showing any significant differences between the two groups. In HIV-infected patients, a baseline healthier metabolomic profile is related to a better response to ART where the lipoprotein profile, mainly large HDL particles, may play a key role.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer

  • Cruz Zambrano, Cristina|||0000-0002-6474-7504
  • Castroviejo-Bermejo, Marta|||0000-0002-8540-5837
  • Gutiérrez-Enríquez, Sara|||0000-0002-1711-6101
  • Llop Guevara, Alba|||0000-0002-7913-9472
  • Ibrahim, Yasir Hussein
  • Gris-Oliver, Albert|||0000-0003-1802-9541
  • Bonache, Sandra|||0000-0002-7395-8143
  • Morancho, Beatriz|||0000-0003-3369-8647
  • Bruna, Alejandra|||0000-0003-1214-9665
  • Rueda, Oscar M.
  • Lai, Zhongwu|||0000-0002-1506-8222
  • Polanska, Urszula|||0000-0003-1017-594X
  • Jones, Gemma|||0000-0002-7567-681X
  • Kristel, Petra
  • de Bustos, L.
  • Guzmán, Marta|||0000-0002-0924-9887
  • Rodríguez, Olga|||0000-0002-0123-9975
  • Grueso, Judit|||0000-0003-1093-7940
  • Montalban, Gemma|||0000-0002-6958-4759
  • Caratù, Ginevra|||0000-0003-1085-8062
  • Mancuso, Francesco M.|||0000-0001-5499-6630
  • Fasani, Roberta|||0000-0003-1630-9988
  • Jiménez, Jose|||0000-0002-2576-1776
  • Howat, William J.
  • Dougherty, Brian|||0000-0002-0093-1142
  • Vivancos, Ana|||0000-0003-2888-6512
  • Nuciforo, Paolo|||0000-0003-1380-0990
  • Serres Creixams, Xavier|||0000-0001-8642-467X
  • Rubio Rodríguez, Isabel Teresa
  • Oaknin, Ana|||0000-0002-3592-7194
  • Cadogan, Elaine|||0000-0002-9757-8305
  • Barrett, J. Carl|||0000-0003-4042-9859
  • Caldas, Carlos|||0000-0003-3547-1489
  • Baselga Torres, Josep
  • Saura Manich, Cristina|||0000-0001-8296-5065
  • Cortés Castán, Javier|||0000-0001-7623-1583
  • Arribas, Joaquín V.|||0000-0002-0504-0664
  • Jonkers, Jos|||0000-0002-9264-9792
  • Diez, Orland|||0000-0001-7339-0570
  • O'Connor, Mark J.|||0000-0003-1823-625X
  • Balmaña Gelpí, Judith|||0000-0002-0762-6415
  • Serra, Violeta|||0000-0001-6620-1065
BRCA1 and BRCA2 (BRCA1/2) -deficient tumors display impaired homologous recombination repair (HRR) and enhanced sensitivity to DNA damaging agents or to poly(ADP-ribose) polymerase (PARP) inhibitors (PARPi). Their efficacy in germline BRCA1/2 (gBRCA1/2)-mutated metastatic breast cancers has been recently confirmed in clinical trials. Numerous mechanisms of PARPi resistance have been described, whose clinical relevance in gBRCA-mutated breast cancer is unknown. This highlights the need to identify functional biomarkers to better predict PARPi sensitivity. We investigated the in vivo mechanisms of PARPi resistance in gBRCA1 patient-derived tumor xenografts (PDXs) exhibiting differential response to PARPi. Analysis included exome sequencing and immunostaining of DNA damage response proteins to functionally evaluate HRR. Findings were validated in a retrospective sample set from gBRCA1/2-cancer patients treated with PARPi. RAD51 nuclear foci, a surrogate marker of HRR functionality, were the only common feature in PDX and patient samples with primary or acquired PARPi resistance. Consistently, low RAD51 was associated with objective response to PARPi. Evaluation of the RAD51 biomarker in untreated tumors was feasible due to endogenous DNA damage. In PARPi-resistant gBRCA1 PDXs, genetic analysis found no in-frame secondary mutations, but BRCA1 hypomorphic proteins in 60% of the models, TP53BP1 -loss in 20% and RAD51 -amplification in one sample, none mutually exclusive. Conversely, one of three PARPi-resistant gBRCA2 tumors displayed BRCA2 restoration by exome sequencing. In PDXs, PARPi resistance could be reverted upon combination of a PARPi with an ataxia-telangiectasia mutated (ATM) inhibitor. Detection of RAD51 foci in gBRCA tumors correlates with PARPi resistance regardless of the underlying mechanism restoring HRR function. This is a promising biomarker to be used in the clinic to better select patients for PARPi therapy. Our study also supports the clinical development of PARPi combinations such as those with ATM inhibitors.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

BET inhibition is an effective approach against KRAS-driven PDAC and NSCLC

  • Jauset González, Toni
  • Massó Vallés, Daniel|||0000-0003-4231-0456
  • Martínez Martín, Sandra
  • Beaulieu, Marie-Eve|||0000-0001-5224-8436
  • Foradada Felip, Laia|||0000-0002-0589-4360
  • Fiorentino, Francesco Paolo
  • Yokota, Jun|||0000-0001-6010-6294
  • Haendler, Bernard
  • Siegel, Stephan
  • Whitfield, Jonathan R.|||0000-0002-4925-7283
  • Soucek, Laura|||0000-0002-4750-7971
Effectively treating KRAS-driven tumors remains an unsolved challenge. The inhibition of downstream signaling effectors is a way of overcoming the issue of direct targeting of mutant KRAS, which has shown limited efficacy so far. Bromodomain and Extra-Terminal (BET) protein inhibition has displayed anti-tumor activity in a wide range of cancers, including KRAS-driven malignancies. Here, we preclinically evaluate the effect of BET inhibition making use of a new BET inhibitor, BAY 1238097, against Pancreatic Ductal Adenocarcinoma (PDAC) and Non-Small Cell Lung Cancer (NSCLC) models harboring RAS mutations both in vivo and in vitro. Our results demonstrate that BET inhibition displays significant therapeutic impact in genetic mouse models of KRAS-driven PDAC and NSCLC, reducing both tumor area and tumor grade. The same approach also causes a significant reduction in cell number of a panel of RAS-mutated human cancer cell lines (8 PDAC and 6 NSCLC). In this context, we demonstrate that while BET inhibition by BAY 1238097 decreases MYC expression in some cell lines, at least in PDAC cells its anti-tumorigenic effect is independent of MYC regulation. Together, these studies reinforce the use of BET inhibition and prompt the optimization of more efficient and less toxic BET inhibitors for the treatment of KRAS-driven malignancies, which are in urgent therapeutic need.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Detrimental effects of testosterone addition to estrogen therapy involve cytochrome P-450-induced 20-HETE synthesis in aorta of ovariectomized spontaneously hypertensive rat (SHR), a model of postmenopausal hypertension

  • Costa, Tiago J.
  • Ceravolo, G. S.
  • Echem, Cinthya
  • Hashimoto, C. M.
  • Costa, B. P.
  • Santos-Eichler, R. A.
  • Oliveira, M. A.
  • Jiménez Altayó, Francesc|||0000-0002-9034-2041
  • Akamine, Eliana Hiromi
  • Dantas, A. P.|||0000-0001-8514-4094
  • Carvalho, M. H. C.
Postmenopausal period has been associated to different symptoms such as hot flashes, vulvovaginal atrophy, hypoactive sexual desire disorder (HSDD) and others. Clinical studies have described postmenopausal women presenting HSDD can benefit from the association of testosterone to conventional hormonal therapy. Testosterone has been linked to development of cardiovascular diseases including hypertension and it also increases cytochrome P-450-induced 20-HETE synthesis which in turn results in vascular dysfunction. However, the effect of testosterone plus estrogen in the cardiovascular system is still very poorly studied. The aim of the present study is to evaluate the role of cytochrome P-450 pathway in a postmenopausal hypertensive female treated with testosterone plus estrogen. For that, hypertensive ovariectomized rats (OVX-SHR) were used as a model of postmenopausal hypertension and four groups were created: SHAM-operated (SHAM), ovariectomized SHR (OVX), OVX treated for 15 days with conjugated equine estrogens [(CEE) 9.6 μg/Kg/day/po] or CEE associated to testosterone [(CEE+T) 2.85 mg/kg/weekly/im]. Phenylephrine-induced contraction and generation of reactive oxygen species (ROS) were markedly increased in aortic rings from OVX-SHR compared to SHAM rats which were restored by CEE treatment. On the other hand, CEE+T abolished vascular effects by CEE and augmented both systolic and diastolic blood pressure of SHR. Treatment of aortic rings with the CYP/20-HETE synthesis inhibitor HET0016 (1 μM) reduced phenylephrine hyperreactivity and the augmented ROS generation in the CEE+T group. These results are paralleled by the increased CYP4F3 protein expression and activity in aortas of CEE+T. In conclusion, we showed that association of testosterone to estrogen therapy produces detrimental effects in cardiovascular system of ovariectomized hypertensive females via CYP4F3/20-HETE pathway. Therefore, our findings support the standpoint that the CYP/20-HETE pathway is an important therapeutic target for the prevention of cardiovascular disease in menopausal women in the presence of high levels of testosterone.